198 related articles for article (PubMed ID: 15165829)
1. Selective action of (-)-2-oxa-4-aminobicyclo[3.1.0]hexane-4,6-dicarboxylate (LY379268), a group II metabotropic glutamate receptor agonist, on basal and phencyclidine-induced dopamine release in the nucleus accumbens shell.
Greenslade RG; Mitchell SN
Neuropharmacology; 2004 Jul; 47(1):1-8. PubMed ID: 15165829
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo evidence for a lack of interaction with dopamine D2 receptors by the metabotropic glutamate 2/3 receptor agonists 1S,2S,5R,6S-2-aminobicyclo[3.1.0]hexane-2,6-bicaroxylate monohydrate (LY354740) and (-)-2-oxa-4-aminobicyclo[3.1.0] Hexane-4,6-dicarboxylic acid (LY379268).
Fell MJ; Perry KW; Falcone JF; Johnson BG; Barth VN; Rash KS; Lucaites VL; Threlkeld PG; Monn JA; McKinzie DL; Marek GJ; Svensson KA; Nelson DL
J Pharmacol Exp Ther; 2009 Dec; 331(3):1126-36. PubMed ID: 19755662
[TBL] [Abstract][Full Text] [Related]
3. The group II metabotropic glutamate receptor agonist (-)-2-oxa-4-aminobicyclo[3.1.0.]hexane-4,6-dicarboxylate (LY379268) and clozapine reverse phencyclidine-induced behaviors in monoamine-depleted rats.
Swanson CJ; Schoepp DD
J Pharmacol Exp Ther; 2002 Dec; 303(3):919-27. PubMed ID: 12438510
[TBL] [Abstract][Full Text] [Related]
4. The metabotropic glutamate 2/3 receptor agonist LY379268 blocked nicotine-induced increases in nucleus accumbens shell dopamine only in the presence of a nicotine-associated context in rats.
D'Souza MS; Liechti ME; Ramirez-Niño AM; Kuczenski R; Markou A
Neuropsychopharmacology; 2011 Sep; 36(10):2111-24. PubMed ID: 21654734
[TBL] [Abstract][Full Text] [Related]
5. Dopamine and 5-HT turnover are increased by the mGlu2/3 receptor agonist LY379268 in rat medial prefrontal cortex, nucleus accumbens and striatum.
Cartmell J; Salhoff CR; Perry KW; Monn JA; Schoepp DD
Brain Res; 2000 Dec; 887(2):378-84. PubMed ID: 11134627
[TBL] [Abstract][Full Text] [Related]
6. The metabotropic glutamate 2/3 receptor agonists LY354740 and LY379268 selectively attenuate phencyclidine versus d-amphetamine motor behaviors in rats.
Cartmell J; Monn JA; Schoepp DD
J Pharmacol Exp Ther; 1999 Oct; 291(1):161-70. PubMed ID: 10490900
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, pharmacological characterization, and molecular modeling of heterobicyclic amino acids related to (+)-2-aminobicyclo[3.1.0] hexane-2,6-dicarboxylic acid (LY354740): identification of two new potent, selective, and systemically active agonists for group II metabotropic glutamate receptors.
Monn JA; Valli MJ; Massey SM; Hansen MM; Kress TJ; Wepsiec JP; Harkness AR; Grutsch JL; Wright RA; Johnson BG; Andis SL; Kingston A; Tomlinson R; Lewis R; Griffey KR; Tizzano JP; Schoepp DD
J Med Chem; 1999 Mar; 42(6):1027-40. PubMed ID: 10090786
[TBL] [Abstract][Full Text] [Related]
8. Metabotropic glutamate receptor modulation of dopamine release in the nucleus accumbens shell is unaffected by phencyclidine pretreatment: In vitro assessment using fast-scan cyclic voltammetry rat brain slices.
Gupta I; Young AMJ
Brain Res; 2018 May; 1687():155-161. PubMed ID: 29524437
[TBL] [Abstract][Full Text] [Related]
9. Activation of metabotropic glutamate (mGlu)2 receptors suppresses histamine release in limbic brain regions following acute ketamine challenge.
Fell MJ; Katner JS; Johnson BG; Khilevich A; Schkeryantz JM; Perry KW; Svensson KA
Neuropharmacology; 2010 Mar; 58(3):632-9. PubMed ID: 19951716
[TBL] [Abstract][Full Text] [Related]
10. Effects of ketamine and N-methyl-D-aspartate on glutamate and dopamine release in the rat prefrontal cortex: modulation by a group II selective metabotropic glutamate receptor agonist LY379268.
Lorrain DS; Baccei CS; Bristow LJ; Anderson JJ; Varney MA
Neuroscience; 2003; 117(3):697-706. PubMed ID: 12617973
[TBL] [Abstract][Full Text] [Related]
11. mGluR2/3 agonist LY379268 rescues NMDA and GABAA receptor level deficits induced in a two-hit mouse model of schizophrenia.
Engel M; Snikeris P; Matosin N; Newell KA; Huang XF; Frank E
Psychopharmacology (Berl); 2016 Apr; 233(8):1349-59. PubMed ID: 26861891
[TBL] [Abstract][Full Text] [Related]
12. Tolerance to the motor impairment, but not to the reversal of PCP-induced motor activities by oral administration of the mGlu2/3 receptor agonist, LY379268.
Cartmell J; Monn JA; Schoepp DD
Naunyn Schmiedebergs Arch Pharmacol; 2000 Jan; 361(1):39-46. PubMed ID: 10651145
[TBL] [Abstract][Full Text] [Related]
13. Anti-epileptic activity of group II metabotropic glutamate receptor agonists (--)-2-oxa-4-aminobicyclo[3.1.0]hexane-4,6-dicarboxylate (LY379268) and (--)-2-thia-4-aminobicyclo[3.1.0]hexane-4,6-dicarboxylate (LY389795).
Moldrich RX; Jeffrey M; Talebi A; Beart PM; Chapman AG; Meldrum BS
Neuropharmacology; 2001 Jul; 41(1):8-18. PubMed ID: 11445181
[TBL] [Abstract][Full Text] [Related]
14. Metabotropic glutamate 2/3 receptors in the ventral tegmental area and the nucleus accumbens shell are involved in behaviors relating to nicotine dependence.
Liechti ME; Lhuillier L; Kaupmann K; Markou A
J Neurosci; 2007 Aug; 27(34):9077-85. PubMed ID: 17715344
[TBL] [Abstract][Full Text] [Related]
15. Activation of group II metabotropic glutamate receptors in the nucleus accumbens shell attenuates context-induced relapse to heroin seeking.
Bossert JM; Gray SM; Lu L; Shaham Y
Neuropsychopharmacology; 2006 Oct; 31(10):2197-209. PubMed ID: 16341024
[TBL] [Abstract][Full Text] [Related]
16. Attenuation of specific PCP-evoked behaviors by the potent mGlu2/3 receptor agonist, LY379268 and comparison with the atypical antipsychotic, clozapine.
Cartmell J; Monn JA; Schoepp DD
Psychopharmacology (Berl); 2000 Mar; 148(4):423-9. PubMed ID: 10928316
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological stimulation of group ii metabotropic glutamate receptors reduces cocaine self-administration and cocaine-induced reinstatement of drug seeking in squirrel monkeys.
Adewale AS; Platt DM; Spealman RD
J Pharmacol Exp Ther; 2006 Aug; 318(2):922-31. PubMed ID: 16675638
[TBL] [Abstract][Full Text] [Related]
18. A selective allosteric potentiator of metabotropic glutamate (mGlu) 2 receptors has effects similar to an orthosteric mGlu2/3 receptor agonist in mouse models predictive of antipsychotic activity.
Galici R; Echemendia NG; Rodriguez AL; Conn PJ
J Pharmacol Exp Ther; 2005 Dec; 315(3):1181-7. PubMed ID: 16123306
[TBL] [Abstract][Full Text] [Related]
19. The potent, selective mGlu2/3 receptor agonist LY379268 increases extracellular levels of dopamine, 3,4-dihydroxyphenylacetic acid, homovanillic acid, and 5-hydroxyindole-3-acetic acid in the medial prefrontal cortex of the freely moving rat.
Cartmell J; Perry KW; Salhoff CR; Monn JA; Schoepp DD
J Neurochem; 2000 Sep; 75(3):1147-54. PubMed ID: 10936197
[TBL] [Abstract][Full Text] [Related]
20. Phencyclidine and glutamate agonist LY379268 stimulate dopamine D2High receptors: D2 basis for schizophrenia.
Seeman P; Guan HC
Synapse; 2008 Nov; 62(11):819-28. PubMed ID: 18720422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
